Listed

Starling Oncology, Inc.

STLNNasdaqCIK 1799191HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$161.3m, Q2 FY2026
Operating income−$4.6m, Q2 FY2026
Net income−$9.8m, Q2 FY2026
Starling Oncology, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m82.0Revenue, Q3 FY2023, three months to 2023-09-30$82.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-13, accession 0001799191-24-000030.Report this figure85.8Revenue, Q4 FY2023, three months to 2023-12-31$85.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-26, accession 0001799191-25-000014. Derived: 12-month figure less the 9-month figure.Report this figure94.7Revenue, Q1 FY2024, three months to 2024-03-31$94.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-14, accession 0001628280-25-025507.Report this figure98.6Revenue, Q2 FY2024, three months to 2024-06-30$98.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-13, accession 0001628280-25-040225.Report this figure99.9Revenue, Q3 FY2024, three months to 2024-09-30$99.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure100Revenue, Q4 FY2024, three months to 2024-12-31$100.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001799191-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure104Revenue, Q1 FY2025, three months to 2025-03-31$104.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure120Revenue, Q2 FY2025, three months to 2025-06-30$119.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure137Revenue, Q3 FY2025, three months to 2025-09-30$136.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure142Revenue, Q4 FY2025, three months to 2025-12-31$142.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001799191-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure147Revenue, Q1 FY2026, three months to 2026-03-31$147.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure161Revenue, Q2 FY2026, three months to 2026-06-30$161.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure
Selling, general and administrative$m28.2Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$28.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-13, accession 0001799191-24-000030.Report this figure28.1Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$28.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-26, accession 0001799191-25-000014. Derived: 12-month figure less the 9-month figure.Report this figure28.5Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$28.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-14, accession 0001628280-25-025507.Report this figure27.9Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$27.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-13, accession 0001628280-25-040225.Report this figure26.6Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$26.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure24.9Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$24.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-12, accession 0001799191-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure25.4Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$25.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure26.9Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$26.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure25.3Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$25.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure28.0Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$28.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-12, accession 0001799191-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure28.2Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$28.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure29.9Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$29.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure
Operating income$m(13.9)Operating income, Q3 FY2023, three months to 2023-09-30−$13.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001799191-24-000030.Report this figure(15.3)Operating income, Q4 FY2023, three months to 2023-12-31−$15.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-26, accession 0001799191-25-000014. Derived: 12-month figure less the 9-month figure.Report this figure(18.0)Operating income, Q1 FY2024, three months to 2024-03-31−$18.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001628280-25-025507.Report this figure(16.4)Operating income, Q2 FY2024, three months to 2024-06-30−$16.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0001628280-25-040225.Report this figure(13.9)Operating income, Q3 FY2024, three months to 2024-09-30−$13.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure(11.9)Operating income, Q4 FY2024, three months to 2024-12-31−$11.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001799191-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(9.9)Operating income, Q1 FY2025, three months to 2025-03-31−$9.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure(11.2)Operating income, Q2 FY2025, three months to 2025-06-30−$11.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure(8.1)Operating income, Q3 FY2025, three months to 2025-09-30−$8.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure(6.9)Operating income, Q4 FY2025, three months to 2025-12-31−$6.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001799191-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(6.5)Operating income, Q1 FY2026, three months to 2026-03-31−$6.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure(4.6)Operating income, Q2 FY2026, three months to 2026-06-30−$4.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure
Interest expense$m1.8Interest expense, Q3 FY2023, three months to 2023-09-30$1.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-13, accession 0001799191-24-000030.Report this figure1.9Interest expense, Q4 FY2023, three months to 2023-12-31$1.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-03-26, accession 0001799191-25-000014. Derived: 12-month figure less the 9-month figure.Report this figure2.0Interest expense, Q1 FY2024, three months to 2024-03-31$2.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-14, accession 0001628280-25-025507.Report this figure2.1Interest expense, Q2 FY2024, three months to 2024-06-30$2.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-13, accession 0001628280-25-040225.Report this figure2.2Interest expense, Q3 FY2024, three months to 2024-09-30$2.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure1.2Interest expense, Q4 FY2024, three months to 2024-12-31$1.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-12, accession 0001799191-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure5.6Interest expense, Q1 FY2025, three months to 2025-03-31$5.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure1.9Interest expense, Q2 FY2025, three months to 2025-06-30$1.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure1.9Interest expense, Q3 FY2025, three months to 2025-09-30$1.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure1.9Interest expense, Q4 FY2025, three months to 2025-12-31$1.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-12, accession 0001799191-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure1.9Interest expense, Q1 FY2026, three months to 2026-03-31$1.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure1.9Interest expense, Q2 FY2026, three months to 2026-06-30$1.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure
Income tax$m0.1Income tax, Q3 FY2023, three months to 2023-09-30$135.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-13, accession 0001799191-24-000030.Report this figure(0.3)Income tax, Q4 FY2023, three months to 2023-12-31−$314.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-26, accession 0001799191-25-000014. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-14, accession 0001628280-25-025507.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-13, accession 0001628280-25-040225.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-12, accession 0001799191-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure(0.1)Income tax, Q2 FY2025, three months to 2025-06-30−$131.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-12, accession 0001799191-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure
Net income$m(17.4)Net income, Q3 FY2023, three months to 2023-09-30−$17.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001799191-24-000030.Report this figure(18.8)Net income, Q4 FY2023, three months to 2023-12-31−$18.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-26, accession 0001799191-25-000014. Derived: 12-month figure less the 9-month figure.Report this figure(19.9)Net income, Q1 FY2024, three months to 2024-03-31−$19.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure(15.5)Net income, Q2 FY2024, three months to 2024-06-30−$15.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure(16.1)Net income, Q3 FY2024, three months to 2024-09-30−$16.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure(13.2)Net income, Q4 FY2024, three months to 2024-12-31−$13.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001799191-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(19.6)Net income, Q1 FY2025, three months to 2025-03-31−$19.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure(17.0)Net income, Q2 FY2025, three months to 2025-06-30−$17.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure(16.5)Net income, Q3 FY2025, three months to 2025-09-30−$16.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure(7.5)Net income, Q4 FY2025, three months to 2025-12-31−$7.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001799191-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(2.5)Net income, Q1 FY2026, three months to 2026-03-31−$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure(9.8)Net income, Q2 FY2026, three months to 2026-06-30−$9.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure
Diluted EPS$ per share(0.19)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0001799191-24-000030.Report this figurenot reported(0.22)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001628280-25-025507.Report this figure(0.17)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0001628280-25-040225.Report this figure(0.18)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figurenot reported(0.21)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure(0.15)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure(0.14)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figurenot reported(0.02)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure(0.08)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure
Basic EPS$ per share(0.19)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001799191-24-000030.Report this figurenot reported(0.22)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001628280-25-025507.Report this figure(0.17)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0001628280-25-040225.Report this figure(0.18)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figurenot reported(0.21)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure(0.15)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure(0.14)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figurenot reported(0.02)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure(0.08)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure

Balance sheet

Long-term debt$79.9m, Q2 FY2026
Shareholders' equity−$24.9m, Q2 FY2026
Starling Oncology, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current assets$m153Current assets, Q3 FY2023, at 2023-09-30$152.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0001628280-23-037896.Report this figure143Current assets, FY2023, at 2023-12-31$143.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-26, accession 0001799191-25-000014.Report this figure141Current assets, Q1 FY2024, at 2024-03-31$141.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001628280-24-023223.Report this figure116Current assets, Q2 FY2024, at 2024-06-30$116.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0001799191-24-000022.Report this figure116Current assets, Q3 FY2024, at 2024-09-30$116.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0001799191-24-000030.Report this figure112Current assets, FY2024, at 2024-12-31$112.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-12, accession 0001799191-26-000007.Report this figure107Current assets, Q1 FY2025, at 2025-03-31$106.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001628280-25-025507.Report this figure105Current assets, Q2 FY2025, at 2025-06-30$104.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0001628280-25-040225.Report this figure110Current assets, Q3 FY2025, at 2025-09-30$110.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure113Current assets, FY2025, at 2025-12-31$112.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure117Current assets, Q1 FY2026, at 2026-03-31$116.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure129Current assets, Q2 FY2026, at 2026-06-30$129.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure
Total assets$m218Total assets, Q3 FY2023, at 2023-09-30$218.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0001628280-23-037896.Report this figure209Total assets, FY2023, at 2023-12-31$209.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-26, accession 0001799191-25-000014.Report this figure205Total assets, Q1 FY2024, at 2024-03-31$204.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001628280-24-023223.Report this figure180Total assets, Q2 FY2024, at 2024-06-30$179.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0001799191-24-000022.Report this figure179Total assets, Q3 FY2024, at 2024-09-30$179.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001799191-24-000030.Report this figure173Total assets, FY2024, at 2024-12-31$172.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-12, accession 0001799191-26-000007.Report this figure164Total assets, Q1 FY2025, at 2025-03-31$164.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001628280-25-025507.Report this figure160Total assets, Q2 FY2025, at 2025-06-30$159.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0001628280-25-040225.Report this figure164Total assets, Q3 FY2025, at 2025-09-30$163.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure165Total assets, FY2025, at 2025-12-31$164.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure168Total assets, Q1 FY2026, at 2026-03-31$168.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure178Total assets, Q2 FY2026, at 2026-06-30$178.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure
Current liabilities$m32.4Current liabilities, Q3 FY2023, at 2023-09-30$32.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0001628280-23-037896.Report this figure34.8Current liabilities, FY2023, at 2023-12-31$34.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-26, accession 0001799191-25-000014.Report this figure45.8Current liabilities, Q1 FY2024, at 2024-03-31$45.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001628280-24-023223.Report this figure35.1Current liabilities, Q2 FY2024, at 2024-06-30$35.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001799191-24-000022.Report this figure46.8Current liabilities, Q3 FY2024, at 2024-09-30$46.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001799191-24-000030.Report this figure52.2Current liabilities, FY2024, at 2024-12-31$52.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-12, accession 0001799191-26-000007.Report this figure59.5Current liabilities, Q1 FY2025, at 2025-03-31$59.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001628280-25-025507.Report this figure64.8Current liabilities, Q2 FY2025, at 2025-06-30$64.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0001628280-25-040225.Report this figure65.6Current liabilities, Q3 FY2025, at 2025-09-30$65.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure71.0Current liabilities, FY2025, at 2025-12-31$71.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure79.4Current liabilities, Q1 FY2026, at 2026-03-31$79.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure94.9Current liabilities, Q2 FY2026, at 2026-06-30$94.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure
Total liabilities$m147Total liabilities, Q3 FY2023, at 2023-09-30$146.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0001628280-23-037896.Report this figure152Total liabilities, FY2023, at 2023-12-31$152.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-26, accession 0001799191-25-000014.Report this figure163Total liabilities, Q1 FY2024, at 2024-03-31$163.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001628280-24-023223.Report this figure150Total liabilities, Q2 FY2024, at 2024-06-30$150.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001799191-24-000022.Report this figure164Total liabilities, Q3 FY2024, at 2024-09-30$163.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001799191-24-000030.Report this figure169Total liabilities, FY2024, at 2024-12-31$169.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-12, accession 0001799191-26-000007.Report this figure159Total liabilities, Q1 FY2025, at 2025-03-31$158.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001628280-25-025507.Report this figure169Total liabilities, Q2 FY2025, at 2025-06-30$168.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0001628280-25-040225.Report this figure176Total liabilities, Q3 FY2025, at 2025-09-30$175.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure180Total liabilities, FY2025, at 2025-12-31$180.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure185Total liabilities, Q1 FY2026, at 2026-03-31$184.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure203Total liabilities, Q2 FY2026, at 2026-06-30$203.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure
Long-term debt$m85.3Long-term debt, Q3 FY2023, at 2023-09-30$85.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-08, accession 0001628280-23-037896.Report this figure86.8Long-term debt, FY2023, at 2023-12-31$86.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-26, accession 0001799191-25-000014.Report this figure88.4Long-term debt, Q1 FY2024, at 2024-03-31$88.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-14, accession 0001628280-24-023223.Report this figure90.0Long-term debt, Q2 FY2024, at 2024-06-30$90.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-13, accession 0001799191-24-000022.Report this figure91.5Long-term debt, Q3 FY2024, at 2024-09-30$91.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-13, accession 0001799191-24-000030.Report this figure93.1Long-term debt, FY2024, at 2024-12-31$93.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-12, accession 0001799191-26-000007.Report this figure73.9Long-term debt, Q1 FY2025, at 2025-03-31$73.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-14, accession 0001628280-25-025507.Report this figure75.0Long-term debt, Q2 FY2025, at 2025-06-30$75.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-13, accession 0001628280-25-040225.Report this figure76.2Long-term debt, Q3 FY2025, at 2025-09-30$76.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure77.4Long-term debt, FY2025, at 2025-12-31$77.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure78.6Long-term debt, Q1 FY2026, at 2026-03-31$78.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure79.9Long-term debt, Q2 FY2026, at 2026-06-30$79.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m71.8Shareholders' equity, Q3 FY2023, at 2023-09-30$71.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0001799191-24-000030.Report this figure57.0Shareholders' equity, FY2023, at 2023-12-31$57.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-12, accession 0001799191-26-000007.Report this figure41.3Shareholders' equity, Q1 FY2024, at 2024-03-31$41.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure29.2Shareholders' equity, Q2 FY2024, at 2024-06-30$29.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure15.5Shareholders' equity, Q3 FY2024, at 2024-09-30$15.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure3.6Shareholders' equity, FY2024, at 2024-12-31$3.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure5.1Shareholders' equity, Q1 FY2025, at 2025-03-31$5.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure(9.0)Shareholders' equity, Q2 FY2025, at 2025-06-30−$9.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure(12.3)Shareholders' equity, Q3 FY2025, at 2025-09-30−$12.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure(15.7)Shareholders' equity, FY2025, at 2025-12-31−$15.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure(16.3)Shareholders' equity, Q1 FY2026, at 2026-03-31−$16.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure(24.9)Shareholders' equity, Q2 FY2026, at 2026-06-30−$24.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure

Cash flow

Operating cash flow$11.9m, Q2 FY2026
Capital expenditure$908.0k, Q2 FY2026
Share repurchases$0, Q4 FY2024
Starling Oncology, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(8.3)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$8.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001799191-24-000030. Derived: 9-month figure less the 6-month figure.Report this figure(3.9)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-26, accession 0001799191-25-000014. Derived: 12-month figure less the 9-month figure.Report this figure(15.9)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$15.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001628280-25-025507.Report this figure(15.7)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$15.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0001628280-25-040225. Derived: 6-month figure less the 3-month figure.Report this figure0.8Operating cash flow, Q3 FY2024, three months to 2024-09-30$819.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001799191-25-000036. Derived: 9-month figure less the 6-month figure.Report this figure4.0Operating cash flow, Q4 FY2024, three months to 2024-12-31$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-26, accession 0001799191-25-000014.Report this figure(5.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$5.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure(10.2)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$10.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001799191-26-000017. Derived: 6-month figure less the 3-month figure.Report this figure(12.6)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$12.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001799191-25-000036. Derived: 9-month figure less the 6-month figure.Report this figure3.2Operating cash flow, Q4 FY2025, three months to 2025-12-31$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001799191-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(2.2)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure11.9Operating cash flow, Q2 FY2026, three months to 2026-06-30$11.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001799191-26-000017. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.9Capital expenditure, Q3 FY2023, three months to 2023-09-30$930.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0001799191-24-000030. Derived: 9-month figure less the 6-month figure.Report this figure0.9Capital expenditure, Q4 FY2023, three months to 2023-12-31$861.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-26, accession 0001799191-25-000014. Derived: 12-month figure less the 9-month figure.Report this figure0.6Capital expenditure, Q1 FY2024, three months to 2024-03-31$610.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0001628280-25-025507.Report this figure1.8Capital expenditure, Q2 FY2024, three months to 2024-06-30$1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-13, accession 0001628280-25-040225. Derived: 6-month figure less the 3-month figure.Report this figure(0.4)Capital expenditure, Q3 FY2024, three months to 2024-09-30−$402.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001799191-25-000036. Derived: 9-month figure less the 6-month figure.Report this figure1.8Capital expenditure, Q4 FY2024, three months to 2024-12-31$1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001799191-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2025, three months to 2025-03-31$328.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure1.2Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001799191-26-000017. Derived: 6-month figure less the 3-month figure.Report this figure0.6Capital expenditure, Q3 FY2025, three months to 2025-09-30$604.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001799191-25-000036. Derived: 9-month figure less the 6-month figure.Report this figure1.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001799191-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure1.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure0.9Capital expenditure, Q2 FY2026, three months to 2026-06-30$908.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001799191-26-000017. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m0.1Share repurchases, Q3 FY2023, three months to 2023-09-30$125.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-13, accession 0001799191-24-000030. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-26, accession 0001799191-25-000014. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-13, accession 0001799191-24-000030. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-26, accession 0001799191-25-000014. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)103.03m, Q2 FY2026
Starling Oncology, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares79.6Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3079,581,304 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0001628280-23-037896.Report this figure73.4Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3173,449,132 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0001628280-24-023223.Report this figure74.1Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3074,119,910 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0001799191-24-000022.Report this figure73.5Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3073,469,101 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0001799191-24-000030.Report this figure74.2Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3174,234,287 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0001628280-25-025507.Report this figure74.7Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3074,748,365 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0001628280-25-040225.Report this figure75.5Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3075,524,823 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure77.1Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3177,098,825 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure93.2Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3093,203,665 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure97.5Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3097,474,797 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001799191-25-000036.Report this figure102Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31101,801,609 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001799191-26-000010.Report this figure103Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30103,031,493 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure

Shares outstanding: 101.92mShares outstanding, period not labelled, at 2026-07-30101,916,115 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001799191-26-000017.Report this figure at Jul 30, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.